Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI

Predictability of the postoperative course of Crohn's disease

1990 • 1,715 citations

National Cooperative Crohn's Disease Study: Results of drug treatment

1979 • 1,257 citations

European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment

1984 • 951 citations

Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection

1995 • 747 citations

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)

1979 • 566 citations

Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables

1997 • 432 citations

Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease

1995 • 270 citations

Oral mesalazine (5‐aminosalicylic acid; Asacol) for the prevention of post‐operative recurrence of Crohn's disease

1994 • 215 citations

Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease

1995 • 210 citations

Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease

1998 • 206 citations

Cigarette smoking and inflammatory bowel disease

1987 • 199 citations

Recurrence and Reoperation for Crohn's Disease

1981 • 174 citations

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

1997 • 166 citations

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study

1993 • 151 citations

Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease.

1993 • 147 citations

Prognostic factors for postoperative recurrence of Crohn's disease

1996 • 142 citations

The Impact of Disease Pattern, Surgical Management, and Individual Surgeons on the Risk for Relaparotomy for Recurrent Crohn's Disease

1996 • 142 citations

Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease

1992 • 132 citations

Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis.

1994 • 124 citations

Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs disease

1996 • 107 citations

Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease.

1976 • 99 citations

Effects of smoking on the presentation and clinical course of inflammatory bowel disease

1997 • 96 citations

Postoperative Treatment with Corticosteroids and Salazosulphapyridine (Salazopyrin^R) after Radical Resection for Crohn’s Disease

1976 • 87 citations

Coated oral 5‐aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease

1990 • 82 citations

Delivery and fate of oral mesalamine microgranules within the human small intestine

1995 • 76 citations

Smoking and sugar intake are separate but interactive risk factors in Crohn's disease.

1988 • 68 citations

Factors affecting recurrence in Crohn's disease

1996 • 61 citations

Oroileal transit of slow release 5-aminosalicylic acid.

1993 • 56 citations

Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease

1994 • 46 citations

Prognosis after surgical treatment for granulomatous enteritis and colitis

1981 • 16 citations